Black Diamond Therapeutics: A Hidden Opportunity Despite Market Indifference

Black Diamond Therapeutics (BDTX) has seen a significant decline in its stock price, but the author sees opportunity in the company. The author has previously expressed optimism about BDTX, and believes that the market is underestimating the company's potential. The author sees BDTX as a leader in the development of precision medicines, and believes that its data is strong. Despite the market's skepticism, the author remains bullish on the company's prospects.